What is ANABV's health score?

ANAPTYSBIO, INC (ANABV) has a TradeApes health score of 68 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ANABV's estimated fair value?

Based on our 5-year discounted cash flow model, ANAPTYSBIO, INC's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is ANABV undervalued or overvalued?

Our model currently rates ANABV as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ANABV... Refresh in a moment for the full analysis.

ANAPTYSBIO, INC (ANABV)

Healthcare Fair Value Medium healthy

Updated: 2026-04-21

TradeApes Score

add

Financial Strength

80 Strong

Operating Trend

80 Strong

Relative Value

60 Healthy

Capital Allocation

30 Weak

Risk

80 Strong

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Excessive stock comp — SBC above 15% of revenue, wealth transfer to employees

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.